These results are consistent with previous studies of breast cancer cell lines, in which 1,1-bis(3′-indolyl)-1-(p-cyanophenyl)methane (DIM-CpPhCN), a NR4A1 antagonist, decreased the phosphorylation of mTOR and mTOR downstream genes [23]. This evidence concerns the gene NR4A1 and breast cancer.